GE HealthCare announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients. The new Revolution RT is being unveiled at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, along with an updated and artificial intelligence (AI)-enhanced version of the Intelligent Radiation Therapy (iRT) platform, which interfaces with the Spectronic magnetic resonance imaging (MRI) Planner. Additionally, the company will showcase the newly acquired MIM Software portfolio, as well as other key innovations from GE HealthCare.
One of the biggest challenges of oncology care is the complexity of the disease — both in the many varieties of cancer, and the disparate ways it can present in each individual patientii — requiring diligence and personalization in diagnosis and treatment. Additionally, treatment often requires the expertise of multiple disciplines and experts related to specific organs and systems in the body, resulting in potential delays to diagnosis and timely treatment. According to research published by the British Medical Journal (BMJ), the mortality risk increases 6-13% for every month a diagnosis is delayediii, therefore, it is critical to streamline the complex oncology care pathway and reduce the time from diagnosis to treatment, ultimately leading to improved patient outcomes.
Also Read: WebMD Ignite Unveils HealthHub Interactive to Support Health Plans’ Clinical Programs
“At GE HealthCare, we are committed to advancing the frontiers of oncology treatment through AI-driven technologies that transform and optimize the care continuum,” said Dr. Taha Kass-Hout, chief technology and science officer of GE HealthCare. “Our showcase at ESTRO this year highlights innovations that will allow clinicians to view the patient’s anatomy with great accuracy, helping facilitate precise tumor targeting while aiming to protect nearby healthy tissue. By integrating these capabilities into our systems, we create a precise, more connected, and efficient care environment that accelerates the delivery of personalized and timely care, with the goal of enabling better patient outcomes. This comprehensive approach empowers clinicians around the globe to tackle the most challenging disease states with precision and efficiency.”
GE HealthCare’s novel radiation therapy solutions, and recent acquisition of the MIM Software portfolio, are designed to reshape the oncology experience around the needs of providers and their patients across the cancer care continuum:
As healthcare systems around the world experience growing volumes of radiation therapy (RT) patients, providers are looking for a CT simulator that enables precision simulation while reducing workflow complexity, with the goal of expediated patient care.iv
GE HealthCare designed its new Revolution RTi with a wide-bore CT platform and high-performance radiation therapy simulation, diagnostic, and interventional capabilities to accommodate more patients, and create a more streamlined standard of care. Revolution RT includes precision radiotherapy simulation that will help enable more accurate imaging, while improving workflow and efficiency, and using deep learning technology to help image the patient with accuracy.
SOURCE: Businesswire